Statera Biopharma, Inc. Long-Term Debt, Maturity, Year Five
Statera Biopharma, Inc. had Long-Term Debt, Maturity, Year Five of $1.46 million as of 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2013-11-08
- 2013-09-30: Long-Term Debt, Maturity, Year Five $1.46M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2013-09-30 | $1.46M 10-Q · filed 2013-11-08 |